# Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women

> **NCT03854396** · PHASE3 · WITHDRAWN · sponsor: **Olivia Cardenas-Trowers, M.D.**

## Conditions studied

- Recurrent Urinary Tract Infection
- Postmenopause
- Postmenopausal Syndrome
- Postmenopausal Symptoms
- Menopause

## Interventions

- **DRUG:** Prasterone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03854396
- **Lead sponsor:** Olivia Cardenas-Trowers, M.D.
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05
- **Primary completion:** 2021-02
- **Final completion:** 2021-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** due to termination of ISR by PI with agreement by grant sponsor
- **Last updated:** 2021-06-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03854396

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03854396, "Clinical Trial on the Preventive Effect of Intravaginal Prasterone on Recurrent Urinary Tract Infections in Postmenopausal Women". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT03854396. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*